IL6 and neoplasm: To determine whether the changes in serum let-7a and IL-6 levels in the early stage of radiotherapy were associated with tumor regression after radiotherapy, we collected serum samples from 27 out of the 70 patients on the 7th day after radiotherapy initiation, when patients had received 10 Gy of radiotherapy.